Tessa’s R&D is based on over three decades of research and development by our Scientific Co-Founder, and internationally recognized clinical scientist, Dr. Malcolm Brenner. His research has shown that the body’s anti-viral immune response can be harnessed as a potent therapy for cancer treatment. Our core platform technology uses a specific subset of immune cells known as Virus-Specific T cells (VSTs) – it has shown comp...
Tessa’s R&D is based on over three decades of research and development by our Scientific Co-Founder, and internationally recognized clinical scientist, Dr. Malcolm Brenner. His research has shown that the body’s anti-viral immune response can be harnessed as a potent therapy for cancer treatment. Our core platform technology uses a specific subset of immune cells known as Virus-Specific T cells (VSTs) – it has shown compelling results in the treatment of solid tumors in clinical trials.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.